Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Change in Cash (2016 - 2025)

Historic Change in Cash for Usana Health Sciences (USNA) over the last 15 years, with Q3 2025 value amounting to -$6.0 million.

  • Usana Health Sciences' Change in Cash fell 11834.12% to -$6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$219.6 million, marking a year-over-year decrease of 47913.6%. This contributed to the annual value of -$148.7 million for FY2024, which is 45476.32% down from last year.
  • According to the latest figures from Q3 2025, Usana Health Sciences' Change in Cash is -$6.0 million, which was down 11834.12% from -$28.2 million recorded in Q2 2025.
  • Usana Health Sciences' Change in Cash's 5-year high stood at $41.0 million during Q4 2022, with a 5-year trough of -$183.2 million in Q4 2024.
  • Its 5-year average for Change in Cash is -$15.7 million, with a median of -$2.1 million in 2022.
  • Its Change in Cash has fluctuated over the past 5 years, first surged by 43858.72% in 2023, then tumbled by 88227.81% in 2024.
  • Usana Health Sciences' Change in Cash (Quarter) stood at -$55.9 million in 2021, then skyrocketed by 173.31% to $41.0 million in 2022, then crashed by 42.81% to $23.4 million in 2023, then crashed by 882.28% to -$183.2 million in 2024, then soared by 96.74% to -$6.0 million in 2025.
  • Its last three reported values are -$6.0 million in Q3 2025, -$28.2 million for Q2 2025, and -$2.1 million during Q1 2025.